Abstract
Downregulation of the tumor suppressor, reversion-inducing cysteine-rich protein with Kazal motifs (RECK) has been reported under hypoxic conditions (Lee et al., 2010); however, the signaling pathways involved in this downregulation have not yet been identified. Hypoxia causes the silencing of RECK mRNA expression, but treatment with inhibitors of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated kinase (MAPK) (PD98059, SP600125, and SB203580 respectively) or their dominant negative mutants recovered RECK suppression induced by hypoxia as analyzed with semiquantitative RT-PCR analysis and a RECK promoter luciferase assay. Hypoxia increased phosphorylation of ERK1/2, JNK and p38 MAPKs. The activities of matrix metalloproteinase (MMP)-9 and MMP-2 were increased under hypoxic conditions but treatment with PD98059, SP600125 and SB203580 inhibited their activation in cancer cells, as seen by zymography. Moreover, treatment with the inhibitors blocked cancer cell migration induced by hypoxia in H-Ras transformed MCF10A mammary cells. RECK suppression under hypoxic conditions was inversely related to HIF-1α expression; however, treatment with PD98059, SP600125 and SB203580 did not influence binding of HIF-1α to the reverse hypoxia responsive element site of the RECK promoter in a DNA precipitation assay. These results suggest that the ERK, JNK and p38 MAPK signaling pathways are indirectly involved in RECK suppression but are not involved in the binding activity of HIF-1α to the reverse hypoxia responsive element site on the RECK promoter under hypoxic conditions.
Similar content being viewed by others
References
Carmeliet, P. and Jain, R. K., Angiogenesis in cancer and other diseases. Nature, 407, 249–257 (2000).
Chang, H. C., Liu, L. T., and Hung, W. C., Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal., 16, 675–679 (2004).
Chang, H. C., Cho, C. Y., and Hung, W. C., Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res., 66, 8413–8420 (2006).
Chen, H., Yan, Y., Davidson, T. L., Shinkai, Y., and Costa, M., Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res., 66, 9009–9016 (2006).
Cowan, K. J. and Storey, K. B., Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol., 206, 1107–1115 (2003).
Fujiwara, S., Nakagawa, K., Harada, H., Nagato, S., Furukawa, K., Teraoka, M., Seno, T., Oka, K., Iwata, S., and Ohnishi, T., Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int. J. Oncol., 30, 793–802 (2007).
Harris, A. L., Hypoxia-a key regulatory factor in tumor growth. Nat. Rev. Cancer, 2, 38–47 (2002).
Hsu, M. C., Chang, H. C., and Hung, W. C., HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J. Biol. Chem., 281, 4718–4725 (2006).
Huang, L. E., Gu, J., Schau, M., and Bunn, H. F., Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A., 95, 7987–7992 (1998).
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., and Abraham, R. T., Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell. Biol., 22, 7004–7014 (2002).
Jeon, H. W. and Lee, Y. M., Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. Mol. Cancer Ther., 9, 1361–1370 (2010).
Jeong, C. H., Lee, H. J., Cha, J. H., Kim, J. H., Kim, K. R., Kim, J. H., Yoon, D. K., and Kim, K. W., Hypoxia-inducible factor-1 alpha inhibits self-renewal of mouse embryonic stem cells in Vitro via negative regulation of the leukemia inhibitory factor-STAT3 pathway. J. Biol. Chem., 282, 13672–13679 (2007).
Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W., and Kim, K. W., Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med., 7, 437–443 (2001).
Kim, S. H., Jeong, J. W., Park, J. A., Lee, J. W., Seo, J. H., Jung, B. K., Bae, M. K., and Kim, K. W., Regulation of the HIF-1α stability by histone deacetylases. Oncol. Rep., 17, 647–651 (2007).
Lee, K. J., Lee, K. Y., and Lee, Y. M., Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Biochim. Biophys. Acta, 1803, 608–616 (2010).
Lee, S. H., Kim, J., Kim, W. H., and Lee, Y. M., Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene, 28, 184–194 (2009).
Masui, T., Doi, R., Koshiba, T., Fujimoto, K., Tsuji, S., Nakajima, S., Koizumi, M., Toyoda, E., Tulachan, S., Ito, D., Kami, K., Mori, T., Wada, M., Noda, M., and Imamura, M., RECK expression in pancreatic cancer: Its correlation with lower invasiveness and better prognosis. Clin. Cancer Res., 9, 1779–1784 (2003).
Mazure, N. M., Chauvet, C., Bois-Joyeux, B., Bernard, M. A., Nacer-Chérif, H., and Danan, J. L., Repression of alphafetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res., 62, 1158–1165 (2002).
Meng, A. X., Jalali, F., Cuddihy, A., Chan, N., Bindra, R. S., Glazer, P. M., and Bristow, R. G., Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother. Oncol., 76, 168–176 (2005).
Michiels, C., Minet, E., Michel, G., Mottet, D., Piret, J. P., and Raes, M., HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life, 52, 49–53 (2001).
Mihaylova, V. T., Bindra, R. S., Yuan, J., Campisi, D., Narayanan, L., Jensen, R., Giordano, F., Johnson, R. S., Rockwell, S., and Glazer, P. M., Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell. Biol., 23, 3265–3273 (2003).
Miyake, K., Yoshizumi, T., Imura, S., Sugimoto, K., Batmunkh, E., Kanemura, H., Morine, Y., and Shimada, M., Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas, 36, e1–e9 (2008).
Narravula, S. and Colgan, S. P., Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol., 166, 7543–7548 (2001).
Noda, M., Kitayama, H., Matsuzaki, T., Sugimoto, Y., Okayama, H., Bassin, R. H., and Ikawa, Y., Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc. Natl. Acad. Sci. U.S.A., 86, 162–166 (1989).
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., Ide, C., Horan, T. P., Arakawa, T., Yoshida, H., Nishikawa, S., Itoh, Y., Seiki, M., Itohara, S., Takahashi, C., and Noda, M., The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell, 107, 789–800 (2001).
Oliver, K. M., Taylor, C. T., and Cummins, E. P., Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases. Arthritis Res. Ther. 11, 215 (2009).
Reddy, K. B., Nabha, S. M., and Atanaskova, N., Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev., 22, 395–403 (2003).
Richard, D. E., Berra, E., Gothié, E., Roux, D., and Pouysségur, J., p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem., 274, 32631–32637 (1999).
Sasahara, R. M., Takahashi, C., Sogayar, M. C., and Noda, M., Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene. Braz. J. Med. Biol. Res., 32, 891–895 (1999).
Shin, I., Kim, S., Song, H., Kim, H. R., and Moon, A., H-Rasspecific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem., 280, 14675–14683 (2005).
Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., Ikawa, Y., Ratzkin, B. J., Arakawa, T., and Noda, M., Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. U.S.A., 95, 13221–13226 (1998).
Takeuchi, T., Hisanaga, M., Nagao, M., Ikeda, N., Fujii, H., Koyama, F., Mukogawa, T., Matsumoto, H., Kondo, S., Takahashi, C., Noda, M., and Nakajima, Y., The membraneanchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin. Cancer Res., 10, 5572–5579 (2004).
Tandara, A. A. and Mustoe, T. A., Oxygen in wound healingmore than a nutrient. World J. Surg., 28, 294–300 (2004).
Tarnawski, A. S., Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig. Dis. Sci., 50, S24–S33 (2005).
Taylor, C. T., Regulation of intestinal epithelial gene expression in hypoxia. Kidney. Int., 66, 528–531 (2004).
Vincenti M. P. and Brinckerhoff C. E., Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J. Cell. Physiol., 213, 355–364 (2007).
Wang, G. L., Jiang, B. H., Rue, E. A., and Semenza, G. L., Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A., 92, 5510–5514 (1995).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jeon, H.W., Lee, KJ., Lee, S.H. et al. Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways. Arch. Pharm. Res. 34, 137–145 (2011). https://doi.org/10.1007/s12272-011-0116-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0116-1